ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells.
The extracellular matrix (ECM) has a key role in facilitating the progression of ovarian cancer and we have shown recently that the secreted ECM protein TGFBI modulates the response of ovarian cancer to paclitaxel-induced cell death.
Main Authors: | Tumbarello, David A. (Author), Temple, Jillian (Author), Brenton, James D. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2012-05-28.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells
by: Tumbarello David A, et al.
Published: (2012-05-01) -
SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells.
by: David A Tumbarello, et al.
Published: (2016-01-01) -
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
by: Wang Ning, et al.
Published: (2012-01-01) -
Genotypic Homogeneity in Distinctive Transforming Growth Factor-Beta Induced (TGFBI) Protein Phenotypes
by: Sang Beom Han, et al.
Published: (2021-01-01) -
Transforming Growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): A Matrix Protein with Dual Functions in Ovarian Cancer
by: Carmela Ricciardelli, et al.
Published: (2012-08-01)